Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer
<p>Abstract</p> <p>Background</p> <p>Mosquito stage malaria vaccines are designed to induce an immune response in the human host that will block the parasite's growth in the mosquito and consequently block transmission of the parasite. A mosquito membrane-feeding a...
Main Authors: | Long Carole A, Sattabongkot Jetsumon, Muratova Olga V, Keister David B, Miura Kazutoyo, Saul Allan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-08-01
|
Series: | Malaria Journal |
Online Access: | http://www.malariajournal.com/content/6/1/107 |
Similar Items
-
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.
by: Yimin Wu, et al.
Published: (2008-07-01) -
A human antibody epitope map of the malaria vaccine antigen Pfs25
by: Niharika Shukla, et al.
Published: (2023-08-01) -
Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant Pfs25
by: David C. Kaslow, et al.
Published: (1992-01-01) -
Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25
by: Stephen W. Scally, et al.
Published: (2017-11-01) -
Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies
by: Kuang-Ting Ko, et al.
Published: (2022-09-01)